Literature DB >> 8031517

Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre.

E J Beck1, L Whitaker, J Kennelly, C McKevitt, J Wadsworth, D L Miller, C Easmon, A J Pinching, J R Harris.   

Abstract

OBJECTIVE: To describe the use of services and associated costs for HIV-infected patients by stage of infection in the context of changing patterns of presentation and survival.
METHODS: A retrospective analysis of inpatient and outpatient case-notes of 335 AIDS patients and a survey of HIV-related care provided by 37 departments at St Mary's Hospital, London. Survival from time of diagnosis of AIDS, time from diagnosis of HIV infection to AIDS, and use and costs of services per patient-year were outcome measures.
RESULTS: During the study period 1 January 1982 to 30 September 1989, 152 AIDS patients were diagnosed before 1987 (group 1) and 183 since 1987 (group 2), most of whom were homosexual men. The median interval of first HIV-related visit to diagnosis of AIDS increased from 0 (group 1) to 264 days (group 2; P < 0.0001). Median survival from AIDS diagnosis increased from 14.6 (group 1) to 21.0 months (group 2; P < 0.02). Group 2 patients used fewer inpatient services than group 1 patients irrespective of disease stage. Symptomatic patients in group 2 used more outpatient services than group 1 patients. Total HIV-related expenditure was lower for patients without AIDS in group 2 than in group 1, while expenditure for AIDS patients remained similar.
CONCLUSION: Earlier patient presentation, a shift from inpatient- to outpatient-based clinical care and increased survival from time of AIDS diagnosis has occurred. Increased drug expenditure was offset by reduced inpatient expenditure. Total expenditure per patient-year was stable; increased survival and introduction of new drugs will increase future lifetime use of resources.

Entities:  

Mesh:

Year:  1994        PMID: 8031517     DOI: 10.1097/00002030-199403000-00013

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

Review 1.  Health economics in HIV disease. A review of the European literature.

Authors:  M Youle; P Trueman; K Simpson
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 2.  Prevention of HIV among adolescents.

Authors:  M J Rotheram-Borus; Z O'Keefe; R Kracker; H H Foo
Journal:  Prev Sci       Date:  2000-03

Review 3.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

4.  The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.

Authors:  E J Beck; K Tolley; A Power; S Mandalia; P Rutter; J Izumi; J Beecham; A Gray; D Barlow; P Easterbrook; M Fisher; J Innes; G Kinghorn; B Mandel; A Pozniak; A Tang; D Tomlinson; I Williams
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

5.  Hospital utilization and costs in a cohort of injection drug users.

Authors:  A Palepu; M W Tyndall; H Leon; J Muller; M V O'Shaughnessy; M T Schechter; A H Anis
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

6.  Cost-effectiveness of highly active antiretroviral therapy in South Africa.

Authors:  Motasim Badri; Gary Maartens; Sundhiya Mandalia; Linda-Gail Bekker; John R Penrod; Robert W Platt; Robin Wood; Eduard J Beck
Journal:  PLoS Med       Date:  2005-12-06       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.